 Notes from the East
Woods musings on opportunities in the life science
marketplace
November 2008
|
|
|
|
Greetings!
|
This month an unfortunate wild boar helps us see the value of knowing where we are going. Please have a read and feel free to let me know what you think. Thanks.
Regards,
Paul Danis Founder and Principal
|
|
|
|
|
|
Wild Boar and Focusing on the Target
|
I was astonished to read how a wild Russian boar was hit by
a car and killed in central Massachusetts.
No one has any idea how this usually southern creature ended up roaming the
local woods until he chose to cross the road.
This reminds me of how some companies bring their products into new
markets only to meet hardship and untimely death.
Going into new markets is a common activity for many
companies that develop new technology.
The research folks come up with a good idea that gets some other folks
excited leading to the development of a new product. All is well and good until some wise guy
asks, "so who is going to buy this?"
Thus, it is like the wild boar in Massachusetts
exploring the markets (the woods) trying to find opportunity (food) and he ends
up as sausage ( he actually did). There
has to be a better way...and there is.
The first approach is to spend considerable time and effort
as early as possible in the development program to determine the best target
applications for the potential new product.
This will give the needed focus to insure that the product is of value
to the customers.
The second approach is to forget the technology and first
look to the marketplace to determine where there is a significant problem. Then, focus the efforts on finding a solution
to the problem. This was illustrated to
me by two companies who were successful with this approach. Ken Rapp, CEO of VelQuest heard people
complaining about having to manage piles of data, results, and notes in the
laboratory. They were trying to use this
information so they can make better decisions in pharmaceutical development.
He then spent a few months talking to the researchers to
really understand the nature of the problem. At that point he started to develop the solution
needed for these people using off-the shelf components. When ready for the market, his electronic
notebook was warmly received and success followed. As Ken said - "begin with the end in mind."
The other example of this was from Stan Lapidus who is the
founder of several successful life science companies. When he raised $400,000 to start Helicos BioSciences, he spent nearly all of this determining clearly the problem that
people had. His assumption is unless you
understand the targeted problem very well, you will probably be wasting money. Helicos is currently one of the leaders in
next-generation genomic sequencing.
So rather than wandering the woods with your new product
searching for opportunity, be sure to have a clear view of the landscape and
the problem that you are solving. You
don't want your products to end up as sausage.
|
Life Science Market Update
|
|
Index
|
October Value
|
Change YTD
|
Yearly High
|
Yearly Low
|
|
EC BioTools
|
595
|
-23%
|
802
|
595
|
|
EC BigPharma
|
663
|
-13%
|
764
|
663
|
|
EC Biotech
|
577
|
-17%
|
726
|
577
|
Life science companies have been somewhat more resistant to the downward spiral of the markets over the last month. However, the tools sector is less in favor these days. Earlier in the month they were all down ~20% for the year. Tools has yet to regain some of these losses, unlike pharma and biotech.
---------------------
Many of the life science
indices currently available are a mixture of various types of companies. In
order to better assess the situation in the different segments, Eastwoods
Consulting has created these price-weighted indices for the sectors of large
pharmaceutical companies, biotech companies, and life science research tools
companies.
-
EC BioTools Index - A, ABI, ACCL, AFFX, BEC, BIO, BRKR,
CALP, DNEX, HBIO, HLCS, ILMN, IVGN, LMNX, PKI, QGEN, SIAL,
TMO, VARI, WAT
-
EC BigPharma Index - JNJ, PFE, GSK, NVS, SNY, MRK, ABT,
LLY, AZN, WYE, BMY, NVO, BAX, TEVA, SGP, RHHBY.PK
-
EB Biotech Index - DNA, AMGN, GENZ, BIIB, CEPH, GILD,
BMRN, AMLN, IDXX, SEPR, OSIP, PDLI, CPHD, ALKS, REGN, MEDX, THRX, HGSI, SGMO,
ENZN, NKTR
-
Prices are
taken at the close of each month.
|
|
| About Eastwoods Consulting
|
Eastwoods Consulting helps companies connect their technologies and products with the life science marketplace. By focusing on the most valuable opportunities, efficiency is increased, and profits grow.
|
Copyright © 2008, Eastwoods Consulting. This
publication may be freely redistributed in full or in part as long as full
attribution including our contact information and web address, are included. Eastwoods is a registered servicemark of Eastwoods Consultng.
|
|
|
|
|